HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A successful case of living donor liver transplantation performed in 7 hours for sub acute fulminant hepatitis].

Abstract
Living donor liver transplantation (LDLT) is the ultimate cure for fulminant hepatitis. Successful outcomes rely on the precise evaluation of the reversibility of hepatic encephalopathy, and a swift execution of necessary examination of both the donor and the recipient. The case was a 63-years old woman, presented with fever and loss of appetite. She was hospitalized for acute hepatitis and treated at a nearby hospital. She was transferred to the tertiary hospital for the acute deterioration of her liver function on the 7th day after the emergence of the initial symptoms. On the 10th day, she showed Grade 2 encephalopathy and underwent plasma exchange. She was transported to our hospital for possible LDLT on the 11th day. CT scan on arrival showed severe atrophy of her liver and no definite brain edema despite acutely deteriorating encephalopathy (Grade 3). LDLT was launched after 7 hours from her transport. She was discharged from the intensive care unit on the 6th day and was discharged without severe complications on 42th day after the LDLT.
AuthorsYoko Zaitsu, Toru Ikegami, Toshirou Masuda, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara
JournalFukuoka igaku zasshi = Hukuoka acta medica (Fukuoka Igaku Zasshi) Vol. 103 Issue 7 Pg. 145-9 (Jul 2012) ISSN: 0016-254X [Print] Japan
PMID22978067 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Acute Disease
  • Female
  • Humans
  • Liver Failure, Acute (therapy)
  • Liver Transplantation
  • Living Donors
  • Middle Aged
  • Plasma Exchange
  • Subacute Care
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: